Clinical trial Recruiting at 7 sites Observational Ages 18 to 21

Registry for young patients with obstructive sleep apnea receiving Inspire therapy

Official title: Inspire Pediatric Post-Approval Registry

Run by Inspire Medical Systems, Inc. · NCT04457154 · Data updated 2026-11-12

This study is looking at how well the Inspire therapy works for young adults aged 18 to 21 with moderate to severe obstructive sleep apnea over five years.

More Obstructive Sleep Apnea trials

Quick facts

Study typeObservational
Ages18 Years to 21 Years
SexAll
Enrollment60 (estimated)
SponsorInspire Medical Systems, Inc.
Industry-sponsored
Locations8 sites (Aurora, Colorado and 7 other locations)
StatusRecruiting
StartedNovember 30, 2021
Main results expectedDecember 2027
Study endsApril 2028
Registry record updatedFebruary 25, 2025
Trial IDNCT04457154 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 18 to 21 with moderate to severe obstructive sleep apnea who have not responded to other treatments.

Probably not a fit

Patients with central or mixed apneas or those who do not meet the eligibility criteria will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This registry is a prospective, multi-center, single-arm study focusing on pediatric patients aged 18 to 21 years who are undergoing implantation of the Inspire Upper Airway Stimulation (UAS) System to treat moderate to severe obstructive sleep apnea (OSA). Participants will be monitored for safety and effectiveness over a five-year period, with data collected at various time points including pre-implant, one month post-implant, and annually for five years. The study aims to gather comprehensive data from at least 60 subjects across multiple clinical centers in the United States.

Why it matters

Potential benefit: If successful, this registry could provide valuable insights into the long-term safety and effectiveness of the Inspire UAS System in young patients with obstructive sleep apnea.

How similar studies have gone: While this registry approach is not novel, similar studies have shown success in evaluating the effectiveness of the Inspire therapy in adult populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Subject is between 18 and 21 years of age;
2. Subject has a diagnosis of moderate to severe OSA (15 ≤ AHI ≤ 65) based on a recent sleep study;
3. Subject has documented failure of, or intolerance to, positive airway pressure treatments, despite attempts to improve compliance;
4. Subject is contraindicated for, or not effectively treated by, adenotonsillectomy;
5. Subject has followed standard of care in considering all other alternative/adjunct therapies;
6. Subject is willing and able to have stimulation hardware permanently implanted and to use the patient remote to activate the stimulation;
7. Subject is willing and able to return for follow-up visits, undergo sleep studies (including in-lab and at-home), and complete questionnaires related to the registry;
8. Subject is willing and able to provide informed consent.

Exclusion Criteria:

1. Subject has a combination of central + mixed apneas \> 25% of the total apnea-hypopnea index (AHI);
2. Subject has any anatomical finding that would compromise the performance of upper airway stimulation, such as the presence of complete concentric collapse of the soft palate;
3. Subject has any condition or procedure that has compromised neurological control of the upper airway;
4. Subject is unable, or does not have the necessary assistance, to operate the patient remote;
5. Subject is pregnant or plans to become pregnant;
6. Subject has an implantable device that may be susceptible to unintended interaction with the Inspire System;
7. Subject has a terminal illness with life expectancy \< 12 months;
8. Any other reason the investigator deems the subject is unfit for participation in the registry.

Where it's running

  • Childrens Hospital of Colorado
    Aurora, Colorado, United States
    Recruiting
  • Duke University
    Durham, North Carolina, United States
    Recruiting
  • Cincinnati Childrens Hospital
    Cincinnati, Ohio, United States
    Recruiting
  • Children's Hospital of Philadelphia
    Philadelphia, Pennsylvania, United States
    Recruiting
  • Children's Hospital of Pittsburgh
    Sewickley, Pennsylvania, United States
    Recruiting
  • University of Texas Southwestern/Children's Hospital of Dallas
    Dallas, Texas, United States
    Recruiting
Show 2 more locations
  • Children's Hospital of the King's Daughters/East Virginia Medical School
    Norfolk, Virginia, United States
    Recruiting
  • Children's Healthcare of Atlanta
    Atlanta, Georgia, United States
    Terminated

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.